Form cover
Page 1 of 1

Breast Cancer Screening Practices: A Clinician Survey

Dear Colleagues,

We are conducting a brief international survey on current breast cancer screening practices and would greatly appreciate your participation. Your insights will help us better understand contemporary clinical approaches, screening preferences, and evolving perspectives across different practice settings worldwide.


Responses are anonymous and will be used for academic research purposes only. Estimated completion time: approximately 3 minutes.


Thank you in advance for your valuable time and contribution.

What is your age group?

What is your age group?
A
B
C
D

Which continent do you practice in?

Which continent do you practice in?
A
B
C
D
E
F

What is your department/speciality?

What is your department/speciality?
A
B
C
D
E
F
G

Which setting do you currently practice in?

Which setting do you currently practice in?
A
B
C
D
E
F

How many years have you been in clinical practice?

How many years have you been in clinical practice?
A
B
C
D

I use a guideline for breast cancer screening in my clinical practice.

I use a guideline for breast cancer screening in my clinical practice.
A
B

I primarily follow one of the guidelines below.(Select all that apply)

I primarily follow one of the guidelines below.(Select all that apply)

I apply a protocol adapted to the conditions and resources of my own institution.

I apply a protocol adapted to the conditions and resources of my own institution.
A
B

I generally avoid screening mammography in average-risk women under 40 years of age.

I generally avoid screening mammography in average-risk women under 40 years of age.
A
B

Annual breast MRI follow-up is concerning in terms of gadolinium safety.

Annual breast MRI follow-up is concerning in terms of gadolinium safety.
A
B

If contrast-enhanced mammography (CEM) were available at my institution, I would prefer it over breast MRI.

If contrast-enhanced mammography (CEM) were available at my institution, I would prefer it over breast MRI.
A
B

Do you have concerns about overdiagnosis and overtreatment in breast cancer diagnosis?

Do you have concerns about overdiagnosis and overtreatment in breast cancer diagnosis?
A
B

Which new imaging modality will most influence breast cancer screening in the next 5-10 years?(Select all that apply)

Which new imaging modality will most influence breast cancer screening in the next 5-10 years?(Select all that apply)

How often do resource limitations affect your choice of screening modality?

How often do resource limitations affect your choice of screening modality?
A
B
C
D

How influential are patient preferences in your choice of screening modality?

How influential are patient preferences in your choice of screening modality?
A
B
C
D

When choosing between MRI and an alternative modality (e.g., CEM) in high-risk patients, what is the most important determining factor?

When choosing between MRI and an alternative modality (e.g., CEM) in high-risk patients, what is the most important determining factor?
A
B
C
D
E

Do you think breast cancer screening should shift from an age-based approach to risk-based strategies?

Do you think breast cancer screening should shift from an age-based approach to risk-based strategies?
A
B
C

Would you use AI-based risk prediction models in your clinical practice to determine breast cancer screening intervals?

Would you use AI-based risk prediction models in your clinical practice to determine breast cancer screening intervals?
A
B
C
D

Do you routinely use digital breast tomosynthesis for screening mammography?

Do you routinely use digital breast tomosynthesis for screening mammography?
A
B
C

Is CEM available at your institution?

Is CEM available at your institution?
A
B
C

Do you recommend supplemental screening for dense breasts?

Do you recommend supplemental screening for dense breasts?
A
B
C
D

Do you use risk-based screening in practice?

Do you use risk-based screening in practice?
A
B
C
D

What is your main concern about AI in breast screening?

What is your main concern about AI in breast screening?
A
B
C
D
E

Additional comments or considerations (optional)